Chronic obstructive pulmonary disease: a complex comorbidity of lung cancer
Journal: Journal of Comorbidity (Vol.1, No. 1)Publication Date: 2011-12-27
Authors : Derek Grose; Robert Milroy;
Page : 45-50
Keywords : chronic obstructive pulmonary disease (COPD); comorbidity; inflammation; lung cancer; oxidative stress; pulmonary;
Abstract
Chronic obstructive pulmonary disease (COPD) is a major burden throughout the world. It is associated with a significantly increased incidence of lung cancer and may influence treatment options and outcome. Impaired lung function confirming COPD is an independent risk factor for lung cancer. Oxidative stress and inflammation may be a key link between COPD and lung cancer, with numerous molecular markers being analysed to attempt to understand the pathway of lung cancer development. COPD negatively influences the ability to deliver radical treatment options, so attempts must be made to look for alternative methods of treating lung cancer, while aiming to manage the underlying COPD. Detailed assessment and management plans utilizing the multidisciplinary team must be made for all lung cancer patients with COPD to provide the best care possible.
Other Latest Articles
- Multiple diseases and polypharmacy in the elderly: challenges for the internist of the third millennium
- Diabetes alone should not be a reason for withholding adjuvant chemotherapy for stage III colon cancer
- Prevalence of disability according to multimorbidity and disease clustering: a population-based study
- Multimorbidity research challenges: where to go from here?
- Improving the health of people with multimorbidity: the need for prospective cohort studies
Last modified: 2015-04-29 03:44:58